Taxanes in the Treatment of Advanced Gastric Cancer

被引：16
|
作者：
Kang, Byung Woog [1 ]
Kwon, Oh-Kyoung [2 ]
Chung, Ho Young [2 ]
Yu, Wansik [2 ]
Kim, Jong Gwang [1 ]
机构：
[1] Kyungpook Natl Univ, Dept Oncol Hematol, Med Ctr, Sch Med,Canc Res Inst, 807 Hogukno, Daegu 41404, South Korea
[2] Kyungpook Natl Univ, Dept Surg, Kyungpook Natl Univ Hosp, Sch Med, Daegu 41494, South Korea
来源：
MOLECULES | 2016年 / 21卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
gastric cancer; taxanes; paclitaxel; docetaxel; chemotherapy; PHASE-III TRIAL; ALBUMIN-BOUND PACLITAXEL; 2ND-LINE CHEMOTHERAPY; 1ST-LINE THERAPY; PLUS CISPLATIN; ANTITUMOR-ACTIVITY; OPEN-LABEL; FLUOROURACIL; DOCETAXEL; ADENOCARCINOMA;
D O I：
10.3390/molecules21050651
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first-or second-line chemotherapy setting for AGC.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Impact of Second-line Chemotherapy on Prognosis: Response of Advanced Gastric Cancer to Taxanes Plus Ramucirumab
    Masuda, Yuka
    Kananazawa, Yoshikazu
    Matsuno, Kunihiko
    Kakinuma, Daisuke
    Sakurazawa, Nobuyuki
    Ando, Fumihiko
    Hagiwara, Nobutoshi
    Nomura, Tsutomu
    Kato, Shunji
    Yoshiyuki, Toshiro
    Yoshida, Hioshi
    ANTICANCER RESEARCH, 2022, 42 (03) : 1599 - 1605
  • [32] Emerging drugs in the treatment of advanced gastric cancer
    Tetzlaff, Eric D.
    Cen, Putao
    Ajanit, Jaffer A.
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 135 - 144
  • [33] Results of esplenectomy in the treatment of advanced gastric cancer
    Martins, Bruno da Costa
    Zilberstein, Bruno
    Eduardo Jacob, Carlos
    Bresciani, Claudio Jose Caldas
    Pertille Ramos, Marcus Fernando Kodaina
    Kenji, Osmar
    Mucerino, Donato
    Cecconello, Ivan
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2007, 20 (02): : 87 - 89
  • [34] Treatment of locally advanced and metastatic gastric cancer
    Klein, HO
    MEDIZINISCHE WELT, 1997, 48 (09): : 401 - 404
  • [35] Randomized phase II trial of taxanes plus 5-fluorouracil for advanced gastric cancer.
    Park, SH
    Bang, SM
    Cho, EK
    Lee, JH
    Shin, DB
    Lee, WK
    Chung, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 345S - 345S
  • [36] Molecular mechanisms of intrinsic resistance to taxanes in gastric cancer
    Galletti, Giuseppe
    Zhang, Chao
    Cleveland, Kyle
    Betel, Doron
    Shah, Manish
    Giannakakou, Paraskevi
    CANCER RESEARCH, 2016, 76
  • [37] Taxanes for the Treatment of Metastatic Breast Cancer
    Gradishar, W. J.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2012, 6 : 159 - 171
  • [38] Nanoparticles for Taxanes Delivery in Cancer Treatment
    Wu, ZhouXue
    Zheng, Jing
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2016, 16 (07) : 6634 - 6647
  • [39] Neoadjuvant treatment with taxanes in breast cancer
    von Minckwitz, Gunter
    BREAST CARE, 2006, 1 (03) : 176 - 184
  • [40] Adjuvant treatment of breast cancer with taxanes
    Wenzel, Catharina
    Steger, Guenther G.
    BREAST CARE, 2006, 1 (03) : 171 - 175
12345